SCHEMBL20527150

SCHEMBL20527150

Cc1cc(C(C)(C)C[N+](=O)[O-])ccc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA1 P02708 1/20 0.37
CHRNG P07510 1/20 0.37
CHRNB1 P11230 1/20 0.37
CHRNB2 P17787 1/20 0.37
SLC6A2 P23975 1/20 0.37
CHRNB4 P30926 1/20 0.37
SLC6A4 P31645 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
SLC6A3 Q01959 1/20 0.37
CHRND Q07001 1/20 0.37
RAB9A P51151 4/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
FBP1 P09467 2/20 0.34
ALDH1A1 P00352 6/20 0.33
TDP1 Q9NUW8 3/20 0.33
CYP3A4 P08684 2/20 0.33
NPC1 O15118 2/20 0.32
LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9768399 0.77 PTPRC (0.39) RAB9AKMT2AMEN1FBP1ALDH1A1
SCHEMBL21176966 0.73 CNR1 (0.49) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL21654058 0.72 ESR1 (0.43)
SCHEMBL10950133 0.71 TAAR1 (0.48) KMT2AFBP1ALDH1A1LMNAMAPK1
SCHEMBL3951881 0.69 ESR1 (0.54) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL799855 0.69 TSHR (0.46) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL22877712 0.69 CNR2 (0.48)
SCHEMBL85170 0.67 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1TDP1CYP3A4
SCHEMBL30648640 0.67 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1TDP1CYP3A4
SCHEMBL3668345 0.66 PDE2A (0.39) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180290998-A1 METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES DOW AGROSCIENCES LLC (US) 2018-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180290998-A1 METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES GPX1, POR, MGAM CHRNA1 3434/4885CHRNG 3432/4885CHRNB1 3737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.